Back to News
Market Impact: 0.25
Cytosorbents To Implement 1-For-20 Reverse Stock Split, Stock Down In Pre-Market
Source: Nasdaq
Company FundamentalsManagement & Governance
Cytosorbents (CTSO) announced a one-for-twenty reverse stock split of its common shares, effective September 8, 2026. The move is typically associated with maintaining listing compliance and can be viewed as a near-term negative signal for equity sentiment, though no financial guidance or earnings figures were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
CTSO-0.25
More News
- Chinese Nvidia rival Enflame soars 206% on stock market debut as AI demand stays hot
- Microsoft AI Focused Data Center Plan to Add 26 Gigawatts of Compute
- Brazil’s Supreme Court shuts down early as political chaos mounts
- Jensen Huang explains why Nvidia will grow an astounding 70% next year
- Oracle's stock jumps 7% on earnings beat as cloud infrastructure revenue more than doubles
- 1-800-FLOWERS (FLWS) Q4 2026 Earnings Call Transcript